Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Heart Assoc, Amazon Partner on Precision Medicine Data

American Heart Association and Amazon Web Services are collecting data from researchers to advance precision medicine in cardiovascular diseases and stroke. . . . → Read More: Heart Assoc, Amazon Partner on Precision Medicine Data

Organ Transplant Start-Up Gains $38M in Early Funds

A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round. . . . → Read More: Organ Transplant Start-Up Gains $38M in Early Funds

Allergan to Option Gene Editing for Eye Diseases

International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard. . . . → Read More: Allergan to Option Gene Editing for Eye Diseases

Report: More Biotech Regulations Needed, and Soon

A new report from the National Academies calls for a more robust and responsive regulatory system to handle an anticipated flood of biotechnology products. . . . → Read More: Report: More Biotech Regulations Needed, and Soon

Precision Medicine, “My Hope for the Future”

A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure. . . . → Read More: Precision Medicine, “My Hope for the Future”

Messenger RNA Engineered to Produce Antibodies

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies

Cancer Blood Test Company Raises $65M in Early Funds

Freenome, a company applying machine learning to analysis of liquid biopsies, is raising $65 million in its first round of venture financing. . . . → Read More: Cancer Blood Test Company Raises $65M in Early Funds

Test of Nasal Skin Cells Found to Detect Lung Cancer

A diagnostic test analyzing the genes in skin cells from nasal passages can detect lung cancer, and the absence of cancer, as accurately as more invasive samples from the airways. . . . → Read More: Test of Nasal Skin Cells Found to Detect Lung Cancer

Duchenne Gene-Editing Company Launched, Raising $5M

A biotechnology start-up is applying a process for editing-out disease-causing mutations to correct the inherited disorder Duchenne muscular dystrophy. . . . → Read More: Duchenne Gene-Editing Company Launched, Raising $5M

Genome Editing Builds Viral Disease Resistance in Pigs

Veterinary researchers used Crispr-Cas9, an emerging genome editing technique, to produce pigs with cells resistant to a common viral disease affecting commercial herds. . . . → Read More: Genome Editing Builds Viral Disease Resistance in Pigs